Janet Elizabeth Codd

Title: Janet Elizabeth Codd: Innovator in Nanoparticulate Compositions

Introduction

Janet Elizabeth Codd is a prominent inventor based in Athlone, Ireland. She has made significant contributions to the field of nanoparticulate formulations, holding a total of 3 patents. Her work focuses on developing innovative compositions that enhance the delivery and effectiveness of pharmaceutical agents.

Latest Patents

One of her latest patents is for controlled-release nanoparticulate compositions. This invention describes formulations that include a nanoparticulate agent and a rate-controlling polymer, which prolongs the release of the agent after administration. The novel compositions are designed to release the agent over a time period ranging from about 2 to 24 hours or longer. Another significant patent involves glipizide compositions, which consist of nanoparticulate formulations of glipizide. The glipizide particles in this composition have an effective average particle size of less than about 2 microns, enhancing their therapeutic efficacy.

Career Highlights

Throughout her career, Janet has worked with notable companies such as Alkermes Pharma Ireland Limited and Flak Pharma International, Ltd. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations and nanoparticulate technology.

Collaborations

Janet has collaborated with esteemed colleagues, including Rajeev A Jain and Maurice Joseph Anthony Clancy. These partnerships have further enriched her research and development efforts in the field.

Conclusion

Janet Elizabeth Codd is a trailblazer in the development of nanoparticulate compositions, with a focus on enhancing drug delivery systems. Her innovative patents and collaborations reflect her commitment to advancing pharmaceutical science.